• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转移性前列腺癌中的低钙血症与甲状旁腺功能

Hypocalcemia and parathyroid function in metastatic prostate cancer.

作者信息

Tandon Prabhat K, Rizvi Ali A

机构信息

Division of Endocrinology, Diabetes, and Metabolism, University of South Carolina School of Medicine, Columbia, South Carolina, USA.

出版信息

Endocr Pract. 2005 Jul-Aug;11(4):254-8. doi: 10.4158/EP.11.4.254.

DOI:10.4158/EP.11.4.254
PMID:16006299
Abstract

OBJECTIVE

To report the occurrence of hypocalcemia in a patient with metastatic prostate cancer, discuss its pathogenesis, and review the related medical literature.

METHODS

An 82-year-old man with a known history of prostate cancer was found to have a serum calcium level of 5.4 mg/dL during an admission to the hospital for small bowel obstruction. A thorough review of his medical history revealed a temporal relationship between the diagnosis of malignant disease and progressive hypocalcemia. A complete evaluation was performed, including laboratory and imaging studies, to ascertain the cause of the hypocalcemia.

RESULTS

The patient had no history of hypocalcemia before the diagnosis of, and initiation of antiandrogen therapy for, advanced prostate cancer. Serum magnesium and phosphorus levels were within normal limits. The serum calcium level responded to therapy in the hospital but remained between 5.8 and 7.1 mg/dL. The parathyroid hormone level was normal, and the 25-hydroxyvitamin D value was low. A 24-hour urine collection showed substantially reduced calcium excretion, and a whole-body bone scan revealed widespread metastatic deposits. These findings were compatible with hypocalcemia related to prostate cancer and bone metastatic lesions.

CONCLUSION

This case serves as a reminder that hypocalcemia can be a manifestation of prostate cancer metastatic to bone. In contrast to the occurrence of secondary hyperparathyroidism in this setting, however, this patient had normal levels of parathyroid hormone. Review of similar previous reports and the causes and implications of a possible functional hypoparathyroid state are discussed.

摘要

目的

报告一例转移性前列腺癌患者发生低钙血症的情况,讨论其发病机制,并复习相关医学文献。

方法

一名82岁有前列腺癌病史的男性因小肠梗阻入院时,血清钙水平为5.4mg/dL。全面回顾其病史发现恶性疾病诊断与进行性低钙血症之间存在时间关联。进行了包括实验室和影像学检查在内的全面评估,以确定低钙血症的病因。

结果

该患者在诊断晚期前列腺癌并开始抗雄激素治疗之前无低钙血症病史。血清镁和磷水平在正常范围内。住院期间血清钙水平对治疗有反应,但仍维持在5.8至7.1mg/dL之间。甲状旁腺激素水平正常,25-羟维生素D值较低。24小时尿钙收集显示钙排泄大幅减少,全身骨扫描显示广泛的转移灶。这些发现与前列腺癌和骨转移灶相关的低钙血症相符。

结论

该病例提醒我们低钙血症可能是前列腺癌骨转移的一种表现。然而,与这种情况下继发性甲状旁腺功能亢进的发生不同,该患者甲状旁腺激素水平正常。讨论了对类似既往报告的回顾以及可能的功能性甲状旁腺功能减退状态的原因和影响。

相似文献

1
Hypocalcemia and parathyroid function in metastatic prostate cancer.转移性前列腺癌中的低钙血症与甲状旁腺功能
Endocr Pract. 2005 Jul-Aug;11(4):254-8. doi: 10.4158/EP.11.4.254.
2
Hypocalcemia with bony metastases in prostate cancer.前列腺癌伴骨转移的低钙血症
J Ayub Med Coll Abbottabad. 2008 Jan-Mar;20(1):138-9.
3
Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases.前列腺癌、血清甲状旁腺激素与骨转移的进展
Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):478-83. doi: 10.1158/1055-9965.EPI-07-2747.
4
Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism.
Am J Med. 1981 Jul;71(1):184-8. doi: 10.1016/0002-9343(81)90292-8.
5
Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.原发性低镁血症中低钙血症的发病机制:终末器官对甲状旁腺激素反应正常,甲状旁腺功能受损。
J Clin Invest. 1973 Jan;52(1):153-60. doi: 10.1172/JCI107159.
6
Hypocalcemia due to osteoblastic metastases and diminished parathyroid reserve in a patient with advanced breast cancer.一名晚期乳腺癌患者因成骨性转移和甲状旁腺储备减少导致低钙血症。
Klin Wochenschr. 1988 Jul 15;66(14):643-6. doi: 10.1007/BF01728807.
7
Hypocalcemic and normocalcemic hyperparathyroidism in patients with advanced prostatic cancer.晚期前列腺癌患者的低钙血症性和血钙正常性甲状旁腺功能亢进
J Clin Endocrinol Metab. 2001 Sep;86(9):4133-8. doi: 10.1210/jcem.86.9.7864.
8
Normal parathyroid hormone levels do not exclude permanent hypoparathyroidism after thyroidectomy.正常甲状旁腺激素水平不能排除甲状腺切除术后永久性甲状旁腺功能减退症。
Thyroid. 2011 Feb;21(2):145-50. doi: 10.1089/thy.2010.0067. Epub 2010 Dec 29.
9
Long-term changes in parathyroid function after subtotal thyroidectomy for graves' disease.Graves病甲状腺次全切除术后甲状旁腺功能的长期变化
World J Surg. 2008 Dec;32(12):2612-6. doi: 10.1007/s00268-008-9754-y.
10
Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer.帕米膦酸给药改善了一名前列腺癌成骨细胞转移患者因“骨饥饿综合征”所致的继发性甲状旁腺功能亢进。
Prostate. 1997 Dec 1;33(4):252-5. doi: 10.1002/(sici)1097-0045(19971201)33:4<252::aid-pros5>3.0.co;2-j.

引用本文的文献

1
Hungry bone syndrome secondary to prostate cancer successfully treated with radium therapy.镭疗成功治疗前列腺癌继发的饥饿骨综合征。
BMJ Case Rep. 2018 Jul 6;2018:bcr-2018-225039. doi: 10.1136/bcr-2018-225039.
2
An integrative model of prostate cancer interaction with the bone microenvironment.前列腺癌与骨微环境相互作用的综合模型。
Math Biosci. 2017 Dec;294:1-14. doi: 10.1016/j.mbs.2017.09.005. Epub 2017 Sep 14.
3
Refractory hypocalcaemia complicating metastatic prostatic carcinoma.转移性前列腺癌并发难治性低钙血症。
BMJ Case Rep. 2015 Jun 29;2015:bcr2015210003. doi: 10.1136/bcr-2015-210003.